US Stock MarketDetailed Quotes

TVTX Travere Therapeutic

Watchlist
  • 18.260
  • +0.400+2.24%
Close Nov 21 16:00 ET
1.59BMarket Cap-3986P/E (TTM)

Travere Therapeutic Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Travere Therapeutic Q3 2024 Earnings Date

Currency：USDOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
60.83M
62.90M
+2.07M
Beat Est.
+63.99%
+69.56%
+3.40%
EPS
-0.67
-0.70
-0.03
Miss Est.
-134.01%
-135.53%
-4.48%
Analyst Rating
Strong Buy

Nov 21, 2024

Travere Therapeutic Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 71.819M--
--2024/Q4-- / 70.891M--
Oct 31, 20242024/Q362.898M / 60.831M--
Aug 1, 20242024/Q254.116M / 52.686M--
May 6, 20242024/Q141.374M / 43.616M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 71.819M--
--2024/Q4-- / 70.891M--
Oct 31, 20242024/Q362.898M / 60.831M--
Aug 1, 20242024/Q254.116M / 52.686M--
May 6, 20242024/Q141.374M / 43.616M--

Unlock Free Earnings Estimates

Travere Therapeutic Earnings Reports

  • Travere Therapeutic | 10-Q: Q3 2024 Earnings Report

    Oct 31 08:41 ET

  • Travere Therapeutic | 8-K: Travere Therapeutics Reports Third Quarter 2024 Financial Results

    Oct 31 08:06 ET

  • Travere Therapeutic | 10-Q: Q2 2024 Earnings Report

    Aug 1 16:42 ET

  • Travere Therapeutic | 8-K: Travere Therapeutics Reports Second Quarter 2024 Financial Results

    Aug 1 16:07 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 21, 2024

    Strong Buy

    • Buy

      86.67%

    • Hold

      13.33%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data